I agree that this site is using cookies. You can find further informations here.
X
George, Saby
176  results:
Search for persons X
?
1

Three- and Seven-month Prostate-specific Antigen Levels as ..:

Parikh, Mamta ; Tangen, Catherine ; Hussain, Maha H.A....
European Urology Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Phase II Trial of Concurrent Nivolumab and Radiation Therap..:

Vaishampayan, Ulka N. ; Heilbrun, Lance ; Vaishampayan, Nitin...
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. 1472-1480 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Safety and effectiveness of the radium‐223–taxane treatment..:

Higano, Celestia S. ; Dizdarevic, Sabina ; Logue, John...
Cancer.  130 (2024)  11 - p. 1930-1939 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Optimization of Radium-223 Treatment of Castration-resistan..:

Shariftabrizi, Ahmad ; Kothari, Shalin ; George, Saby...
The Oncologist.  28 (2023)  3 - p. 246-251 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Characterization and Management of Adverse Reactions From t..:

Motzer, Robert ; George, Saby ; Merchan, Jaime R...
The Oncologist.  28 (2023)  6 - p. 501-509 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Adjuvant nivolumab plus ipilimumab versus placebo for local..:

Motzer, Robert J ; Russo, Paul ; Grünwald, Viktor...
The Lancet.  401 (2023)  10379 - p. 821-832 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Editorial: Molecular genetics and therapeutic advances in r..:

Nanus, David M. ; Finke, James H. ; George, Saby
Frontiers in Oncology.  12 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Phase I Dose-Escalation Study of the Safety and Pharmacokin..:

Petrylak, Daniel P. ; Eigl, Bernhard J. ; George, Saby...
Clinical Cancer Research.  30 (2023)  1 - p. 63-73 , 2023
Link: https://doi.org/10.1158/..
 
?
9

Metastatic renal cell carcinoma to the pancreas and other s..:

Duarte, Cassandra ; Hu, Junxiao ; Beuselinck, Benoit...
eClinicalMedicine.  60 (2023)  - p. 102018 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Ver..:

Motzer, Robert J. ; Russo, Paul ; Grünwald, Viktor...
Targeted Oncology.  18 (2023)  5 - p. 639-641 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Long-term outcomes with nivolumab plus ipilimumab versus su..:

Rini, Brian I ; Signoretti, Sabina ; Choueiri, Toni K...
Journal for ImmunoTherapy of Cancer.  10 (2022)  12 - p. e005445 , 2022
Link: https://doi.org/10.1136/..
 
?
12

FRACTION-RCC: nivolumab plus ipilimumab for advanced renal ..:

Choueiri, Toni K ; Kluger, Harriet ; George, Saby...
Journal for ImmunoTherapy of Cancer.  10 (2022)  11 - p. e005780 , 2022
Link: https://doi.org/10.1136/..
 
?
13

Conditional survival and long‐term efficacy with nivolumab ..:

Motzer, Robert J. ; McDermott, David F. ; Escudier, Bernard...
Cancer.  128 (2022)  11 - p. 2085-2097 , 2022
Link: https://doi.org/10.1002/..
 
?
14

First-line Nivolumab plus Ipilimumab Versus Sunitinib in Pa..:

Albiges, Laurence ; Tannir, Nizar M. ; Burotto, Mauricio...
European Urology.  81 (2022)  3 - p. 266-271 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Evaluation of tumor microenvironment and biomarkers of immu..:

Brown, Landon C ; Zhu, Jason ; Desai, Kunal...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005249 , 2022
Link: https://doi.org/10.1136/..
 
1-15